137 related articles for article (PubMed ID: 25827205)
21. Tumor Stage-Related Role of Radiotherapy in Patients with an External Auditory Canal and Middle Ear Carcinoma.
Choi J; Kim SH; Koh YW; Choi EC; Lee CG; Keum KC
Cancer Res Treat; 2017 Jan; 49(1):178-184. PubMed ID: 27384159
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
[TBL] [Abstract][Full Text] [Related]
23. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
[TBL] [Abstract][Full Text] [Related]
24. A dosimetric evaluation on applying RTOG-based and CT/MRI-based delineation methods to brachial plexus in radiotherapy of nasopharyngeal carcinoma treated with helical tomotherapy.
Li CH; Wu VW; Chiu G
Br J Radiol; 2019 Oct; 92(1102):20170881. PubMed ID: 29714086
[TBL] [Abstract][Full Text] [Related]
25. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
[TBL] [Abstract][Full Text] [Related]
26. External auditory canal cholesteatoma in patients given radiotherapy for nasopharyngeal carcinoma.
Yu SS; Lee KJ; Lin YS
Head Neck; 2015 Dec; 37(12):1794-8. PubMed ID: 24989318
[TBL] [Abstract][Full Text] [Related]
27. Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy.
Lin J; Lv X; Niu M; Liu L; Chen J; Xie F; Zhong M; Qiu S; Li L; Huang R
Neuroimage Clin; 2017; 14():610-621. PubMed ID: 28348952
[TBL] [Abstract][Full Text] [Related]
28. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
[TBL] [Abstract][Full Text] [Related]
29. Surgical approach for treatment of carcinoma of the anterior wall of the external auditory canal.
Hosokawa S; Mizuta K; Takahashi G; Okamura J; Takizawa Y; Hosokawa K; Yamatodani T; Mineta H
Otol Neurotol; 2012 Apr; 33(3):450-4. PubMed ID: 22314922
[TBL] [Abstract][Full Text] [Related]
30. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
[TBL] [Abstract][Full Text] [Related]
32. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
33. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
[TBL] [Abstract][Full Text] [Related]
34.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
35. Ceruminous gland carcinoma of the external auditory canal presenting as chronic otitis media.
Selcuk A; Ensari S; Cetin MA; Sak SD; Dere H
B-ENT; 2007; 3(4):195-9. PubMed ID: 18265725
[TBL] [Abstract][Full Text] [Related]
36. Parotid perfusion in nasopharyngeal carcinoma patients in early-to-intermediate stage after low-dose intensity-modulated radiotherapy: evaluated by fat-saturated dynamic contrast-enhanced magnetic resonance imaging.
Cheng CC; Chiu SC; Jen YM; Chang HC; Chung HW; Liu YJ; Chiu HC; Chen CY; Huang GS; Juan CJ
Magn Reson Imaging; 2013 Oct; 31(8):1278-84. PubMed ID: 23664679
[TBL] [Abstract][Full Text] [Related]
37. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
Liu K; Han Y; Ma B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1177-83. PubMed ID: 24616996
[TBL] [Abstract][Full Text] [Related]
38. Fractionated stereotactic radiotherapy with vagina carotica protection technique for local residual nasopharyngeal carcinoma after primary radiotherapy.
Liu F; Xiao JP; Xu YJ; Zhang Y; Xu GZ; Gao L; Yi JL; Luo JW; Huang XD; Huan FK; Fang H; Wan B; Li YX
Chin Med J (Engl); 2012 Jul; 125(14):2525-9. PubMed ID: 22882934
[TBL] [Abstract][Full Text] [Related]
39. Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Lin L; Zhang WJ; Peng YL; Chen L; Tang LL; Mao YP; Ma J; Sun Y
Sci Rep; 2015 Sep; 5():13525. PubMed ID: 26323586
[TBL] [Abstract][Full Text] [Related]
40. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
